n(g),n(g')-dimethyl-l-arginine has been researched along with Atrial Fibrillation in 16 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We previously performed a trial of intravenous landiolol hydrochloride during and after cardiac surgery (the PASCAL trial) and demonstrated a preventive effect on postoperative atrial fibrillation (AF)." | 9.16 | Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. ( Hata, M; Hirayama, A; Kunimoto, S; Nakai, T; Sezai, A; Shiono, M; Yoshitake, I, 2012) |
| "The purpose of this study was to determine whether high asymmetric dimethylarginine (ADMA) levels could predict early recurrence of atrial fibrillation (AF) after successful electrical cardioversion (CV)." | 9.13 | Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion. ( Feng, W; Qu, X; Song, Y; Xia, W; Yu, Y; Zhang, X, 2008) |
| "Elevated plasma levels of asymmetric dimethylarginine (ADMA) have been reported to be associated with endothelial dysfunction, inflammation, and oxidative stress in multiple cardiovascular diseases." | 7.79 | Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram. ( Chang, SL; Chao, TF; Chen, SA; Hsieh, MH; Hu, YF; Lin, YJ; Lo, LW; Lu, TM; Tsao, HM; Tuan, TC, 2013) |
| "It has been reported that elevation of asymmetric dimethylarginine (ADMA) concentration is involved in atrial fibrillation (AF) process." | 7.77 | Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. ( Dechun, Y; Shuqin, S; Wei, F; Xiufen, Q; Yang, L; Yang, Y; Yanwei, Y; Ying, S, 2011) |
| "LAA thrombus was detected in 27 subjects by transesophageal echocardiography." | 5.42 | Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients with non-valvular atrial fibrillation. ( Chi, Y; Duan, T; Rong, Y; Shao, Y; Wang, Y; Xia, W, 2015) |
| "We previously performed a trial of intravenous landiolol hydrochloride during and after cardiac surgery (the PASCAL trial) and demonstrated a preventive effect on postoperative atrial fibrillation (AF)." | 5.16 | Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. ( Hata, M; Hirayama, A; Kunimoto, S; Nakai, T; Sezai, A; Shiono, M; Yoshitake, I, 2012) |
| "The purpose of this study was to determine whether high asymmetric dimethylarginine (ADMA) levels could predict early recurrence of atrial fibrillation (AF) after successful electrical cardioversion (CV)." | 5.13 | Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion. ( Feng, W; Qu, X; Song, Y; Xia, W; Yu, Y; Zhang, X, 2008) |
| "Pathways of oxidative stress, nitric oxide bioavailability and L-arginine derivatives are hypothesized to be related to atrial fibrillation (AF)." | 3.83 | ADMA, subclinical changes and atrial fibrillation in the general population. ( Appelbaum, S; Atzler, D; Bauer, C; Blankenberg, S; Böger, RH; Hoffmann, B; Lackner, KJ; Münzel, T; Ojeda, FM; Ramuschkat, M; Schnabel, RB; Schwedhelm, E; Sinning, CR; Wild, PS; Zeller, T, 2016) |
| "Elevated plasma levels of asymmetric dimethylarginine (ADMA) have been reported to be associated with endothelial dysfunction, inflammation, and oxidative stress in multiple cardiovascular diseases." | 3.79 | Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram. ( Chang, SL; Chao, TF; Chen, SA; Hsieh, MH; Hu, YF; Lin, YJ; Lo, LW; Lu, TM; Tsao, HM; Tuan, TC, 2013) |
| "It has been reported that elevation of asymmetric dimethylarginine (ADMA) concentration is involved in atrial fibrillation (AF) process." | 3.77 | Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. ( Dechun, Y; Shuqin, S; Wei, F; Xiufen, Q; Yang, L; Yang, Y; Yanwei, Y; Ying, S, 2011) |
| "LAA thrombus was detected in 27 subjects by transesophageal echocardiography." | 1.42 | Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients with non-valvular atrial fibrillation. ( Chi, Y; Duan, T; Rong, Y; Shao, Y; Wang, Y; Xia, W, 2015) |
| "Patients with AF-recurrence were older, had a higher proportion of hypertension and long-standing persistent AF." | 1.40 | Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation. ( Alasady, M; Chakrabarty, A; Lau, DH; Lim, HS; Roberts-Thomson, KC; Sanders, P; Schultz, C; Willoughby, SR; Worthley, MI; Young, GD, 2014) |
| "Thirty five patients had persistent atrial fibrillation (AF)≥ 4months." | 1.38 | The impact of rapid atrial pacing on ADMA and endothelial NOS. ( Bode-Böger, SM; Bukowska, A; Dobrev, D; Goette, A; Hammwöhner, M; Lendeckel, U; Martens-Lobenhoffer, J; Medunjanin, S; Ravens, U; Scalera, F; Weinert, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 13 (81.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Büttner, P | 1 |
| Bahls, M | 1 |
| Böger, RH | 3 |
| Hindricks, G | 1 |
| Thiele, H | 1 |
| Schwedhelm, E | 3 |
| Kornej, J | 1 |
| Chao, TF | 1 |
| Lu, TM | 1 |
| Lin, YJ | 1 |
| Tsao, HM | 1 |
| Chang, SL | 1 |
| Lo, LW | 1 |
| Hu, YF | 1 |
| Tuan, TC | 1 |
| Hsieh, MH | 1 |
| Chen, SA | 1 |
| McEvoy, M | 1 |
| Schofield, P | 1 |
| Smith, W | 1 |
| Agho, K | 1 |
| Mangoni, AA | 1 |
| Soiza, RL | 1 |
| Peel, R | 1 |
| Attia, J | 1 |
| Lim, HS | 2 |
| Willoughby, SR | 2 |
| Schultz, C | 2 |
| Chakrabarty, A | 1 |
| Alasady, M | 2 |
| Lau, DH | 2 |
| Roberts-Thomson, KC | 1 |
| Worthley, MI | 2 |
| Young, GD | 2 |
| Sanders, P | 2 |
| Polovina, MM | 1 |
| Lip, GY | 1 |
| Potpara, TS | 1 |
| Stamboul, K | 1 |
| Lorin, J | 1 |
| Lorgis, L | 1 |
| Guenancia, C | 1 |
| Beer, JC | 1 |
| Touzery, C | 1 |
| Rochette, L | 1 |
| Vergely, C | 1 |
| Cottin, Y | 1 |
| Zeller, M | 1 |
| Xia, W | 2 |
| Wang, Y | 1 |
| Duan, T | 1 |
| Rong, Y | 1 |
| Chi, Y | 1 |
| Shao, Y | 1 |
| Ramuschkat, M | 1 |
| Appelbaum, S | 1 |
| Atzler, D | 2 |
| Zeller, T | 1 |
| Bauer, C | 1 |
| Ojeda, FM | 1 |
| Sinning, CR | 1 |
| Hoffmann, B | 1 |
| Lackner, KJ | 1 |
| Wild, PS | 1 |
| Münzel, T | 1 |
| Blankenberg, S | 1 |
| Schnabel, RB | 2 |
| Maas, R | 1 |
| Wang, N | 1 |
| Yin, X | 1 |
| Larson, MG | 1 |
| Levy, D | 1 |
| Ellinor, PT | 1 |
| Lubitz, SA | 1 |
| McManus, DD | 1 |
| Magnani, JW | 1 |
| Vasan, RS | 1 |
| Benjamin, EJ | 1 |
| Lao, MC | 1 |
| Liu, LJ | 1 |
| Luo, CF | 1 |
| Lu, GH | 1 |
| Zhai, YS | 1 |
| Chen, XL | 1 |
| Gao, XR | 1 |
| Qu, X | 1 |
| Yu, Y | 1 |
| Zhang, X | 1 |
| Feng, W | 1 |
| Song, Y | 1 |
| Goette, A | 1 |
| Hammwöhner, M | 1 |
| Bukowska, A | 1 |
| Scalera, F | 1 |
| Martens-Lobenhoffer, J | 1 |
| Dobrev, D | 1 |
| Ravens, U | 1 |
| Weinert, S | 1 |
| Medunjanin, S | 1 |
| Lendeckel, U | 1 |
| Bode-Böger, SM | 1 |
| Yang, L | 1 |
| Xiufen, Q | 1 |
| Shuqin, S | 1 |
| Yang, Y | 1 |
| Ying, S | 1 |
| Yanwei, Y | 1 |
| Wei, F | 1 |
| Dechun, Y | 1 |
| Sezai, A | 1 |
| Nakai, T | 1 |
| Hata, M | 1 |
| Yoshitake, I | 1 |
| Shiono, M | 1 |
| Kunimoto, S | 1 |
| Hirayama, A | 1 |
| Gan, C | 1 |
| Leong, DP | 1 |
| Brooks, AG | 1 |
| Kistler, PM | 1 |
| Kalman, JM | 1 |
| Cengel, A | 1 |
| Sahinarslan, A | 1 |
| Biberoğlu, G | 1 |
| Hasanoğlu, A | 1 |
| Tavil, Y | 1 |
| Tulmaç, M | 1 |
| Ozdemir, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Correlation Of CoAGulation Biomarkers and Atrial Fibrillation Burden in Patients Post Catheter Ablation: the COAG-AF Pilot Study[NCT04947657] | 20 participants (Anticipated) | Observational | 2021-09-22 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for n(g),n(g')-dimethyl-l-arginine and Atrial Fibrillation
| Article | Year |
|---|---|
Endothelial (dys)function in lone atrial fibrillation.
Topics: Arginine; Atrial Fibrillation; Biomarkers; E-Selectin; Endocardium; Endothelium, Vascular; Humans; P | 2015 |
2 trials available for n(g),n(g')-dimethyl-l-arginine and Atrial Fibrillation
| Article | Year |
|---|---|
Asymmetric dimethylarginine concentration and early recurrence of atrial fibrillation after electrical cardioversion.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Electric Countershock; Female; Humans; Male; Middle | 2008 |
Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; | 2012 |
13 other studies available for n(g),n(g')-dimethyl-l-arginine and Atrial Fibrillation
| Article | Year |
|---|---|
Arginine derivatives in atrial fibrillation progression phenotypes.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Cohort Studies; Disease Progression; Female; Homoar | 2020 |
Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Cardiovascular Diseases; Coronary Angiograph | 2013 |
Memory impairment is associated with serum methylarginines in older adults.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Cohort Studies; Diabetes Mellitus; Education | 2014 |
Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Catheter Ablation; Electrocardiography; Endothelium | 2014 |
Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Biomarkers; Chromatography, High Pressure Li | 2015 |
Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients with non-valvular atrial fibrillation.
Topics: Aged; Arginine; Atrial Appendage; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Nitric Oxi | 2015 |
ADMA, subclinical changes and atrial fibrillation in the general population.
Topics: Adult; Aged; Arginine; Atrial Fibrillation; Biomarkers; Chromatography, Liquid; Echocardiography; El | 2016 |
Asymmetric dimethylarginine, related arginine derivatives, and incident atrial fibrillation.
Topics: Aged; Arginine; Atrial Fibrillation; Biomarkers; Cohort Studies; Female; Humans; Incidence; Male; Mi | 2016 |
[Effect of asymmetrical dimethylarginine for predicting pro-thrombotic risk in atrial fibrillation].
Topics: Arginine; Atrial Fibrillation; Cardiovascular Diseases; Heart Atria; Humans; Stereoisomerism; Thromb | 2016 |
The impact of rapid atrial pacing on ADMA and endothelial NOS.
Topics: Aged; Animals; Arginine; Atrial Fibrillation; Calcium-Binding Proteins; Disease Models, Animal; Endo | 2012 |
Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation.
Topics: Arginine; Atrial Fibrillation; Biomarkers; Body Surface Potential Mapping; Catheter Ablation; Cohort | 2011 |
Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm.
Topics: Aged; Antithrombin III; Arginine; Atrial Fibrillation; Catheter Ablation; CD40 Ligand; Enzyme Inhibi | 2013 |
Asymmetrical dimethylarginine level in atrial fibrillation.
Topics: Acute Disease; Arginine; Atrial Fibrillation; Chromatography, High Pressure Liquid; Chronic Disease; | 2008 |